series-b
Stage
About
LiberoThera develops new therapeutics targeting membrane proteins including GPCRs using proprietary membrane protein synthesis technologies such as cell-free membrane protein preparation and non-canonical amino acid incorporation.
Explore LiberoThera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.